ISSN 1006-298X      CN 32-1425/R

Chinese Journal of Nephrology, Dialysis & Transplantation

Previous Articles     Next Articles

Update on diagnosis and treatment of transplant glomerulopathy

  

  • Online:2020-06-28 Published:2020-07-07

Abstract: Transplant glomerulopathy (TG) is a group of disorders that are characterized histopathologically by glomerular capillary loop duplication with pauciimmunocomplex deposition.Cardinal clinical symptoms of TG included proteinuria,serum creatinine elevation and hypertension.It is the leading cause of longterm allograft failure.Although chronic and repetitive endothelial injury is conceived to be the contributing factor,the exact pathomechanism of TG remains elusive.Chronic active antibodymediated rejection (cABMR) is the predominant etiology for TG,with alloantibody,T cellmediated rejection (TCMR),thrombotic microangiopathy (TMA) and hepatitis C virus (HCV) infection have all been reported to cause TG.Early intervention may obtain a more desirable result for TG that predominantly targets prevention.

Key words: renal transplantation,transplant glomerulopathy,clinicopathology spectra,treatment  , prognosis